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The genus Yersinia is composed of eleven species, three of which (Y. pseudotuberculosis, Y. 
enterolitica, and Y. pestis) are human pathogens. It is believed that Y. pseudotuberculosis is 
the predecessor of Y. pestis, which causes plague, and as a result there is a close genetic link 
between the two species. Each of the pathogenic species possess an approx. 70 kb plasmid 
known as pYV, (pCD1 in Y. pestis and pYVe in Y. enterocolitica) which is essential for virulence. 
The plasmid codes for a Type III Secretion system (T3SS) composed of structural proteins 
which form an injectisome (analogous to a hypodermic needle) and effectors which when 
combined disarm host immune cells through disruption of processes such as actin 
polymerisation as well as inducing cellular apoptosis. Expression of these proteins, usually 
referred to as Yops, are known to be regulated by both the environment (through 
temperature and calcium concentration) and the bacterial cell-to-cell signalling system known 
as Quorum Sensing (QS).  
The QS system plays an important role in the maintenance of the pYV plasmid within the 
population. Previous work has shown that transcriptional regulators and signal synthase 
mutants in the QS system are unable to secrete Yops, and virulence plasmid levels in a 
population fall rapidly in these mutants when compared to the parent. It is hypothesised that 
QS plays a key role in the maintenance of the pYV plasmid.  
This study aims to investigate the link between QS and plasmid maintenance through the 
targeting of the copA/copB promoters. copA and copB both control the plasmid replication 
initiation protein RepA through repression of the repA gene. They play a key role in plasmid 
replication and therefore plasmid maintenance. lux-based reporter fusion technology was 
used, which contains a luxCDABE cassette, and copA/copB promoters. When gene expression 
occurs, light is emitted from the cell, which can be measured to indicate the level of this 
expression. The promoters of copA and copB will be used as a marker for plasmid 
maintenance by examining expression in the parent and QS mutant backgrounds. These 
fusions were successfully created, however further data was not possible to obtain given the 
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1.1 Yersinia background  
1.1.1 The History, Epidemiology, and Current State of Yersinia 
The genus Yersinia which belongs to the Enterobacteriaceae family, is composed of between 
eleven and twenty-seven different species, three of which are medically important (1; 2) Of 
these, the most historically significant is Y. pestis – the causative agent of plague. This 
organism has been responsible for an estimated 200 million deaths after spreading 
throughout the world numerous times, including three pandemics, one of which was the most 
fatal pandemic recorded to date – The Black Death (3). 
Y. pseudotuberculosis is an enteric bacterium, attributed as the cause of Far East Scarlet-Like 
Fever (FESLF) – also known as Izumi fever in Japan. FESLF typically arises sporadically in the 
northern hemisphere (Europe, North America, Russia, and Japan). Whilst the number of cases 
worldwide are relatively low, it is a seasonal disease, peaking during winter (4). The organism 
is a zoonotic pathogen that is typically acquired following ingestion of contaminated food or 
water, however as the symptoms manifest as gastroenteritis, accurate epidemiological 
figures are difficult to gauge. Whilst Y. pseudotuberculosis is the cause of FESLF, it more 
commonly presents itself as Yersiniosis, a zoonotic sporadic gastrointestinal infection. 
However, the main causative organism of Yersiniosis is Y. enterocolitica (5). This may be a 
result of several factors – the first of these being the reservoirs both organisms reside in. Y. 
enterocolitica has a wide range of these including pigs, cattle, dogs, cats, and rodents. 
Whereas Y. pseudotuberculosis’ range includes farm animals, rodents, and birds. The 
possibility of spreading via domestic pets increases the odds of this happening when handling 
them regularly versus wild animals that may not necessarily be in regular contact with 
humans. Another potential reason for Y. enterocolitica more commonly causing infection than 
Y. pseudotuberculosis is the former causes infection consistently whereas the latter is more 
seasonal and therefore most cases are seen in winter (6). Y. enterocolitica is spread via the 
faecal-oral route usually from animals – contaminated water, milk and food are the main 
source of infection and as such outbreaks occasionally occur from common exposure rather 
than person-to-person transmission (7). 
Y. pestis is a zoonotic bacterium and as such is transmitted between animals (and humans) 
via fleas. Plague foci can currently be found in 33 countries (figure 1.1), with 10 countries 
reporting human cases between 2014-19. Hundreds of human cases of the plague do still 
occur along with a number of deaths, primarily in the Democratic Republic of Congo, Peru, 
and Madagascar (9). Whilst plague can be treated with antibiotics, it has a high case-fatality 
ratio of 30-100% when left untreated (dependent upon the location where the infection takes 
hold [10; 11]). There are three manifestations of plague – Pneumonic, Bubonic and 
Septicaemic plague – each with different clinical features. Each is the result of the organism 
infecting a different location in the body. Pneumonic plague is caused when Y. pestis infects 
the lungs, causing pneumonia; septicaemic plague is caused when the organism multiplies in 
the blood, causing septicaemia; bubonic plague is caused by the infection of lymph nodes, 
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leading to acute painful lymphadenitis (bubo) (13). As such, WHO class the organism as a re-
emerging dangerous pathogen. This classification, and recent events in Madagascar (August 
to November 2017, 2348 cases of plague were confirmed, including 202 deaths), suggest that 
Yersinia pestis still requires significant attention (9; 12).  
  
 
1.1.2 The Yersinia Genus 
Historically, Y. pseudotuberculosis has been attributed as the predecessor of Y. pestis, with 
the latter being a recently evolved near-identical subclone of the former. This event was 
thought to have occurred anywhere between 1,500 and 20,000 years ago (14). Both Y. 
pseudotuberculosis and Y. pestis belong to a single clade in the Yersinia phylogenetic tree (15), 
whereas Y. enterocolitica is on a different clade entirely. Since the divergence from Y. 
pseudotuberculosis, analysis has shown that Y. pestis has 32 newly acquired chromosomal 
genes and 2 newly acquired Y. pestis-specific plasmids. However, more significantly it appears 
317 genes became pseudogenes or were deleted from Y. pestis – meaning up to 13% of Y. 
pseudotuberculosis genes are no longer functioning in Y. pestis. As a result of both reductive 
evolution via massive gene loss and extensive genome rearrangements, pre-existing gene 
expression pathways have been lost or modified. This may be more important than the newly 




Figure 1.1: The global distribution of natural plague foci as of March 2016 where red 
indicates the presence of natural plague foci based on recent information and historical 




1.2 Virulence in Yersinia 
1.2.1 Adhesins 
Bacteria require adhesion for colonisation of host cells and tissues, contributing to bacterial 
pathogenesis. Bacterial adhesion allows bacteria to attach/adhere to other cells and surfaces 
(17). Adhesins are split into different categories dependent upon their structure, assembly 
pathways, and surface export mechanisms; in the case of the human pathogenic Yersinia 
adhesins, there are four categories – the most important adhesins being Yersinia adhesin A 
(YadA), and invasin (InvA). Both YadA and InvA fall into the autotransporter (AT) adhesins (18). 
YadA is a non-fimbrial adhesin encoded on the pYV plasmid (with the exception of Yersinia 
pestis, in which it is a pseudogene and as a result is inactive) and is responsible for Yersinia 
contact with a variety of host cells such as macrophages and epithelial cells. YadA is expressed 
in abundance at 37oC and above, coating the outer surface of the cell. It is apparent that this 
adhesin has multiple functions, which may include acting as a docking system for the organism 
when invading a host cell. This allows the T3SS injectisome to attach to the target cell and 
deliver effector Yops. It is an essential adhesin to Y. enterocolitica pathogenicity but not as 
essential to Y. pseudotuberculosis due to its role being interchangeable with invasin (18; 19; 
20). 
InvA is a chromosomally encoded adhesin that mediates both attachment and entry into host 
cells. It is also present in Y. pseudotuberculosis and Y. enterocolitica, but in Y. pestis it is an 
inactive pseudogene. Regulation of invasin occurs through temperature and, in the case of Y. 
enterocolitica, also pH – the peak expression is typically at pH 8 and 25oC or at pH 5.5 and 
37oC (21). InvA binds to target receptors, known as β1-integrins on the host cell surface. Upon 
the binding of InvA, the integrins form clusters and as a result, the host cell cytoskeleton is 
rearranged, ultimately promoting phagocytosis – leading to the internalisation of the 
bacterial cell into the host epithelial cells (22; 23). 
Another example of adhesin is the attachment-invasion locus (ail). Ail is a small β-barrel 
protein expressed in all three pathogenic Yersinia spp. but at varying temperatures – 37oC in 
both Y. pseudotuberculosis and Y. enterocolitica, but also at 26oC to a lesser extent in Y. pestis. 
It is an important factor that influences cell adhesion, promotion of Yop delivery to host cells, 
cell invasion and serum resistance (18; 21; 24). There are many other adhesins that are either 
minor or more specific to a particular spp. These include the pH 6 antigen (psa), Plasminogen 







1.2.2 Virulence Plasmid 
The 3 human pathogenic strains of Yersinia spp. possess an approx. 70 kb virulence plasmid 
(pYV in Y. pseudotuberculosis, pYVe in Y. enterocolitica, and pCD1 in Y. pestis) which has been 
described as an anti-host genome. pYV (figure 1.2), also known as the Yop (Yersinia outer 
protein) regulon encodes proteins that are required for the survival and replication of Yersinia 
to occur within the host’s lymphoid tissues during infection. The plasmid encodes for the Yop 
virulon which consists of Yop proteins and a type III secretion system (T3SS), also known as 
Ysc (27; 28). It is well documented that the virulence plasmid is absolutely necessary for 
virulence in Yersinia. Studies have shown that when pYV is absent Yersinia spp. exhibit a 
severe reduction or attenuation of virulence (29; 30; 31). 
Figure 1.2: A map of the Y. enterolitica serotype O:8 virulence plasmid pYVe8081, 
indicating replication and partition regions, significant genes and IS elements. The inner 
circle indicates the scale of the plasmid in kb. The outer ring genes are transcribed anti-
clockwise, with the inner ones being clockwise. Green indicates genes that make up the 
LCR (low calcium response) stimulon. Purple indicates yadA and genes linking to 
replication and partition functions are highlighted by yellow. Pink genes are those that 
have been previously identified but the function is unknown and potential new genes 
are indicated by light blue. Dark blue indicates IS elements. This plasmid is similar to pYV 
seen in Y. pseudotuberculosis, with a few minor differences including spyA, spyB, and 
spyC, rather than copA and copB seen within pYV. Along with this, pYVe also contains an 
additional Yop effector – YopT. Source: (26). 
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The Yop virulon allows the bacteria to disarm the host’s immune cells by disrupting their 
communication, or via inducing cellular apoptosis by injecting the effector proteins into the 
cell. There are 2 categories of Yop proteins – intracellular effectors, and those that form the 
translocation apparatus. The Yops involved in forming the translocation apparatus are 
deployed at the bacterial surface to deliver their effectors into eukaryotic cells via their 
plasma membrane. When the bacteria come into contact with eukaryotic cells, the Yops are 
secreted and controlled by virulon proteins, which are thought to form a plug complex and 
close the bacterial secretion channel (27; 28; 32). 
1.2.3 Type III Secretion System 
The Ysc injectisome (figure 1.3) spans the two bacterial membranes and the peptidoglycan 
layer, whilst also protruding from the bacteria. The injectisome can be split into three 
sections: the basal body, the needle, and the pore complex (33). The basal body is formed 
through a series of ring structures, starting with the scaffold proteins. A ring is formed of YscC 
in the bacterial outer membrane. This is followed by another larger ring formed on the inner 
membrane consisting of YscD and YscJ (MS ring). The basal body is anchored into the 
peptidoglycan layer by the rings connecting to one another – hence the scaffold name. (34; 
Figure 1.3: A diagram depicting the structural components of the Yersinia Ysc 
injectisome. The basal body where the injectisome sits is made up of the inner 
membrane (IM), peptidoglycan layer (PGN) and the outer membrane (OM). The needle 
tip complex (LcrV) and translocation pore (YopB/YopD) can be seen piercing the host 
membrane (HM). Purple/Dark blue indicates scaffold proteins: YscC, YscD, YscJ; Blue 
indicates cytoplasmic components: YscQ (C-ring) and YscN, YscL, YscK (ATPase complex); 
Green indicates: YscI (rod) and YscF (needle); light orange indicates export apparatus 
proteins: YscR, YscS, YscT, YscU and YscV; Dark orange/white indicates the pore complex: 




35). YscN, YscL and YscK form an ATPase complex whilst the C ring forms, comprised of YscQ. 
Both these components associate with the scaffold proteins, at which point the basal body is 
almost complete (36). Meanwhile in a separate pathway, YscRSTUV assembles within the 
inner membrane separately from the scaffold proteins. This is the beginning of the export 
apparatus. The two assembly pathways then crossover as YscJ, within the MS ring, recruits 
the export apparatus. Once the export apparatus and ATPase complex have joined the 
scaffold, the basal body is complete and can begin to export secretion substrates (33; 37). 
The rest of the construction of the Ysc injectisome can be split into three stages: early, middle, 
and late. The early stage begins following the completion of the basal body, where early 
substrates are translocated. These substrates include YscP, YscI, YscF, YscX, YscO, and YopR 
(38). YscI forms a substrate passage across from the inner membrane to the outer membrane. 
Once the passage is formed, YscF is secreted, which forms the injectisome needle through 
polymerization. YscP is known to regulate the length of the needle, whilst YopR is important 
for the early stages of needle assembly (the precise reasons for this are unclear) (38; 39). The 
individual roles of YscXYO are all unknown, though they are thought to be required for the 
export of these early substrates. YscP also has another role in which it interacts with YscU in 
the export apparatus upon completion of the needle. This causes YscU to undergo 
autocleavage, triggering a substrate specificity switch – leading to the middle stage (33; 40; 
41). 
Translocators (‘middle’ Yops), including YopB, YopD, and LcrV are secreted throughout the 
middle stage prior to cell contact. LcrV is secreted and polymerizes at the end of the needle 
to form a needle tip complex (figure 1.3) (33; 42). The translocation pore proteins (YopB and 
YopD) use the needle tip complex as a platform to insert themselves into the host cell 
membrane and combine to form a multimeric complex, at which point the transition to late 
stage secretion can be made (41; 42; 43). 
The T3SS is activated at a temperature of 37oC, alongside the presence of millimolar 
concentrations of calcium (Ca2+) – conditions which represent a mammalian hosts’ 
intracellular environment. It is believed that the formation of the LcrG-LcrV complex is 
important for Ca2+ regulated secretion of YopM (44; 45). 
To prevent the degradation of the T3SS proteins, and prevent premature oligomerisation, 
specific chaperones are required. Class I chaperones assist the effector Yops, class II 
chaperones assist the pore-forming translocators and class III chaperones associate with 
needle subunits (46; 47).  
Following adhesion and attachment to a host cell, the T3SS transfers a variety of virulence 
factors into the eukaryotic target cell. These factors, which are present in all three pathogenic 
Yersinia spp. are known as Yersinia effector proteins. They are synthesised within the bacterial 
cytoplasm and are eventually translocated via the T3SS. Four of these proteins (YpkA, YopE, 
YopT, and YopH) function to disrupt the cytoskeleton of host cells. YpkA, YopE and YopT also 
carry out the targeting of an important group of cell signalling components that are involved 
in phagocytosis. YpkA (or YopO in Y. enterocolitica) inhibits phagocytosis following association 
with RhoA family proteins; it binds to and phosphorylates actin, which is then used by Y. 
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enterocolitica for the titration of host regulators that are responsible for actin polymerisation 
(48; 49). YopE is a mimic of the GTPase-activating proteins for eukaryotes and as a result has 
the ability to disrupt the actin cytoskeleton, which in turn inhibits phagocytosis (45; 48). YopT 
cleaves post-translationally modified Rho GTPases (supressing RhoA mediated signalling), 
preventing the phagocytic cup (important in bacterial internalisation) from forming (50). This 
protein also inhibits the assembly of focal adhesion complexes, which are essential for 
macrophage migration (51). YopH is a multi-functional protein that disrupts pathways linked 
to both innate and adaptive immunity. Following the binding of YadA/Invasin to β1-integrins, 
YopH prevents autophagy; it also prevents macrophages from carrying out phagocytosis by 
phosphorylating focal adhesion complex proteins – this disrupts any links to the actin 
cytoskeleton (25; 48; 49). 
Another two effectors (YopJ and YopM) downregulate features of the immune system. YopJ 
(or YopP in Y. enterocolitica) is an acetyltransferase that catalyses the acylation of kinases, 
which inhibits their ability in the activation of the release of NF-Kβ (an inducer of pro-
inflammatory cytokine production) (41; 52). It was also discovered that YopJ holds an 
important role through inhibition of caspase-1 within macrophages (53). Lastly, YopM is 
translocated directly inside macrophages and it has been suggested that it can self-deliver 
into certain human cells (54). Although not fully characterised, it is theorised that YopM may 
interact with and down-regulate a number of pro-inflammatory cytokines. It is also suggested 
that it counteracts the innate immune system through encouraging the depletion of natural 
killer cells in several environments throughout a host, along with binding to caspase-1, 
preventing pyroptosis (25; 49; 55; 56) 
1.2.4 Y. pestis Additional Virulence Plasmids 
Yersinia pestis possesses two additional virulence plasmids – pPCP (also known as pPst) and 
pMT (also known as pFra). pPCP encodes for the plasminogen activator Pla protease/adhesin, 
which converts plasminogen to plasmin. Plasmin causes degradation of extracellular matrices, 
allowing the rapid invasion of host cells (57). Along with encoding for the surface protein Pla, 
pPCP encodes for the pesticin activity protein (Pst) and pesticin immunity protein (pim). 
Pesticin is a protein toxic to closely related bacterial strains including Y. pestis, Y. 
enterocolitica, Y. pseudotuberculosis and some Escherichia coli strains. Pim gives the organism 
immunity against its own pesticin by decreasing the sensitivity of the organism to the protein, 
preventing suicide via pesticin (57; 58). Whilst similar to a toxin/antitoxin system, the aim is 
to destroy other organisms rather than for plasmid maintenance. pMT encodes for the 







1.3 Plasmid maintenance 
1.3.1 General Plasmid Maintenance 
Maintaining a stable plasmid copy number across a dividing bacterial population is essential 
to prevent plasmid loss during partition of newly replicated plasmids to daughter cells during 
cell division. If the plasmid(s) is not successfully transferred to both daughter cells those 
without the plasmid have a lower metabolic load and as a result can outcompete those 
possessing the plasmid. This can lead to an organism losing a plasmid over time if the 
environmental conditions do not apply sufficient selective pressure. Conversely, high stress 
environments may force bacteria to retain their plasmids (60; 61). 
One of the most common systems employed to ensure a stable plasmid population is 
maintained, is through the par system, consisting of a centromere-like DNA site and two 
different proteins: a centromere-binding protein and a partition NTPase. There are three 
types of partition system. The type I par loci encodes for a Walker motif-containing ATPase; 
type II encodes actin-like proteins, and type III encodes for tubulin-like proteins (62; 63; 64; 
65). These mechanisms are present in a variety of low copy-number plasmids as these 
plasmids are typically too large to copy in great numbers.   
The general mechanism for par systems can be split into three different steps (figure 1.4), the 
first of which requires multiple centromere-binding proteins to bind to the centromere. This 
goes onto form the partition complex, which is a higher order nucleoprotein complex. The 
second step is where the plasmids within the cell pair together. The final step involves the 
partition complex recruiting a partition NTPase, which directs plasmid separation to opposite 
poles of the bacterial cell from their pair (62). This leads to the need for close control of the 
location of the few plasmids they possess. High-copy number plasmids are another 
mechanism to avoid plasmid loss. These plasmids are copied in huge numbers, reducing the 
chances of a daughter cell being produced without a plasmid. In theory if plasmids are 
distributed randomly in a cell, the probability of losing this plasmid is linked directly to the 
Figure 1.4: The three stages of generalised plasmid partitioning.  The partition complexes 
are formed and the plasmids (represented by circles) pair up [1], before the NTPase 
molecules interact with the complexes and mediate plasmid separation [2] before cell 




number of copies. However, there are pitfalls with this as there is an increase in the metabolic 
load on the cell (66; 67). 
Another approach taken is plasmid-free cell removal which involves the killing and/or growth 
inhibition of cells lacking plasmids. The first of these approaches is complementation of 
chromosomal mutation. An essential part of chromosomal DNA is encoded on the plasmid 
rather than the chromosome itself. As a result, cells lacking the plasmid cannot grow (68). 
Another way in which this approach can be taken is through environmental selection. 
Environmental changes/cues can impact a population in a variety of ways and this system 
uses environmental cues that would usually kill cells to its advantage. Those with the plasmid 
may have some in-built environmental response or resistance to deal with these changes, but 
those that are plasmid-free are unable to grow (68; 69). Lastly the post-segregational killing 
system, also known as the toxin-antitoxin (TA) system is used to kill plasmid-free cells. In this 
case the plasmid takes an active role to kill the daughter cells while preserving those that 
contain the plasmid. These systems encode for both a toxin and the corresponding antitoxin. 
The plasmids produce both the stable toxin and unstable antitoxin to counteract it. This leads 
to the cells that possess the plasmid surviving and those without the plasmid/antitoxin die. 
Five classes of TA systems have been discovered thus far, each with slightly differing 
mechanisms but the same outcome (70). 
1.3.2 Plasmid Maintenance in Yersinia 
Yersinia use a type I par, and in some cases also TA systems, to prevent plasmid loss from 
occurring. The type I par consists of the genes parA, parB, and parS. An operon is formed out 
of the genes parA and parB with the partition site parS directly downstream. The protein ParB 
and double-stranded DNA stimulate the ATPase ParA (71; 72; 73; 74). 
TA systems have been observed in both Y. enterocolitica and Y. pestis (a combination of the 
HigBA, HicAB, MqsRA, Phd-Doc, and RelBE families of TA system that have been identified in 
the chromosome of the CO92 strain) but not Y. pseudotuberculosis (75; 76; 77). Whilst some 
information is known about TA systems within Yersinia, they remain largely uncharacterised. 
However, sequencing has shown that a ParDE family TA system is common within some 
Yersinia spp. plasmids, most notably pCD1 in Y. pestis and the chromosome of Y. 
enterocolitica. While it is believed these play a role in plasmid maintenance, the extent of this 
contribution and the biological role of the system required further investigation (78). 
The replicase RepA has control over the copy number of the pYV plasmid to ensure there is a 
balance between enough plasmids to avoid plasmid loss but not too many so that the 
metabolic load is too heavy. The protein RepA consists of two domains, an N-terminal and a 
C-terminal (79; 80). RepA initiates replication at the ori, though how the protein acts down to 
a molecular level is unknown. As a result of its role, RepA is negatively regulated at both a 
transcriptional and post-transcriptional level through repression by CopA and CopB in the 
absence of host cells. The transcriptional repressor CopB interacts with the repA promoter, 
preventing repA from being activated. Meanwhile, the antisense RNA (asRNA) CopA prevents 
translation of signal peptides (which are required for RepA translation) as it binds to the 5’ 




1.4 Quorum Sensing in Yersinia 
Quorum sensing (QS) is a mode of cell-to-cell communication, used to promote collective 
behaviour within a population (seen in both Gram-positive and Gram-negative bacteria 
along with eukaryotic organisms) and is driven by the production and transduction of signal 
molecules in a population density dependent manner. The larger the density, the greater 
the overall synthesis of the signal molecules and once the signal reaches the required 
threshold concentration, the initiation of a signal transduction cascade is triggered. At this 
point a population-wide change in behaviour occurs in response to the messages spread. 
Some examples of these messages include information around population density, the 
environment, metabolism and motility (85; 86; 87; 88; 89; 90). 
One of the first discovered examples of this is the marine bacterium Vibrio fischeri, in which 
the acyl homoserine lactone (AHL) synthase luxI encodes for the AHL synthase, whilst the luxR 
gene encodes for AHL binding and transcriptional activator LuxR. Observations have found 
that at higher cell density bioluminescence increases (83; 92; 93). 
These AHL signal molecules diffuse or are actively transported out of the cell into the 
extracellular environment and as the population density of the bacteria increases, so does the 
concentration of signalling molecules. Once the threshold concentration is reached, the 
molecules re-enter the cell and bind with the LuxR homologue receptor proteins (87). The 
AHL/LuxR homologue then binds to the promoter region of the lux box, which induces the 
expression of genes downstream. In this case the genes luxCDABE are activated, resulting in 
bioluminescence (92; 93). This establishes a positive feedback loop that then promotes 
synchronised gene expression within the bacterial population (94; 95) (figure 1.6). 
Figure 1.5: The RepA plasmid maintenance system. RepA binds to and activates the 
origin of replication (ori), however in the absence of host cells, CopB interacts with the 
repA promoter – preventing its activation. The non-coding RNA CopA is antisense to 
repA and acts post-transcriptionally - preventing the translation of signal peptides 
required for repA translation. Source: (84) 
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In Yersinia, a similar set of orthologs are in use. In Y. pseudotuberculosis there are two sets, 
known as ypsI and ytbI (AHL synthase genes), and ypsR and ytbR (transcriptional regulators). 
Similarly, Y. pestis has two pairs of orthologs, which are yspI/yspR and ypeI/ypeR (86; 96). 
Lastly, in Y. enterocolitica there is a single pairing of yenI/yenR (88). The system in Yersinia 
works in an analogous fashion to the Vibrio fischeri QS system. However, there is crossover 
between each of the pairings as the system is arranged in a hierarchical structure. For 
example, in Y. pseudotuberculosis the YpsR protein regulates the ytbR/I locus, indicating the 
orthologs overlap in terms of regulation (97). 
The YpsR/YpsI and YtbR/YtbI QS systems in Y. pseudotuberculosis were found to fine tune 
motility through influencing the expression of flhDC and fliA, which are both key regulators of 
the motility cascade (97). This relationship is similar within Y. enterocolitica, but Y. pestis is 
non-motile and as a result the association between QS and the motility cascade regulators 
may be different when compared to both Y. pseudotuberculosis and Y. enterocolitica (88; 98; 
99). The relationship between QS and biofilm formation has also previously been investigated, 
specifically on the nematode Caenorhabditis elegans. The investigation suggested a link 
between the two as AHLs were produced in nematode associated biofilms and AHL 
synthase/transcriptional regulator genes mutated within Y. pseudotuberculosis strains or 
those expressing AHL-degrading enzymes lead to attenuation of biofilm formation (86). QS 
also has an important role in the T3SS, through repression rather than the positive regulation 
seen in motility. Evidence for this was provided through the mutation of flagellar components 
(flhDC, flhA and fliA) and multiple QS genes (such as ytbI, ypsR, ytbR and the double mutants 
Figure 1.6: A diagram encompassing the steps of the gram-negative QS system within a 
bacterial cell when the threshold concentration of AHL signalling molecules is reached. 




ypsR/ytbR and ytbI/ypsI) (86). It has recently been suggested that lcrF (Also known as VirF in 
Y. enterocolitica) is negatively regulated by QS and that ymoA is positively regulated at both 
22oC and 37oC (100). LcrF is a temperature-regulated activator of the pYV Yop regulon and is 
key to the assembly, and regulation of the T3SS (along with regulating yadA expression), in 
both Y. pseudotuberculosis and Y. enterocolitica (101; 102). YmoA is a histone-like protein that 
modulates the expression of lcrF and as a result is also key to virulence in Yersinia (103) 
 
1.5 Previous Work and Aims of This Study 
Whilst not fully established, the link between QS and virulence plasmid maintenance has been 
suggested. Data gathered on Y. enterocolitica suggested QS plays a role during infection 
through the regulation of pYVe partition via SpyA (present in Y. enterocolitica and 
homologous to ParA/CopA). Naturally, the data also evidenced a link between QS and plasmid 
loss, highlighted when comparing pYVe plasmid loss in both a parent and yenI mutant strain. 
The yenI mutant (the same as the parent strain but lacking the yenI gene) had a higher rate 
of plasmid loss when compared to the parent, indicating QS plays a role in plasmid 
maintenance, and as a result also plasmid loss. However, more work is required to understand 
the contribution of QS down to a molecular basis (88).  
To begin filling this gap in our current knowledge, the aim of this study was to investigate the 
link between QS and plasmid maintenance through the targeting of copA/copB promoters. 
Both copA and copB negatively regulate the replicase gene repA, which controls the copy 
number of the pYV plasmid (figure 1.5). As a result, copA and copB play a key role in controlling 
plasmid loss/maintenance (81; 82). If QS is related to the promotion of these genes, it can be 
confirmed that QS does play a role in plasmid maintenance/loss.  
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2 Materials and Methods 
2.1 Growth Media and Growth Conditions 
E. coli strains were grown at 37oC, shaking at 200 rpm in LB broth (104) unless otherwise 
stated. Y. pseudotuberculosis strains were grown at 30oC in YLB broth (105) shaking at 200 
rpm. Appropriate antibiotics were added at the following concentrations: chloramphenicol 
(Cm) 10 µg / ml, gentamicin (Gm) 10 µg / ml, nalidixic acid (Nal) 22.5 µg / ml, and ampicillin 
(Amp) 100 µg / ml. When grown on plates 15 g / l agar was added to the media. 
 
2.2 Bacterial Strains and Plasmids 
2.2.1 Bacterial Strains 
All bacterial strains used throughout this study are listed in Table 2.1. 
Table 2.1: Bacterial Strains used 
Bacterial Strain Description Source 
E. coli 
DH5α E. coli K-12 cloning strain, (AmpR) (106) 
S17-1 λ–pir A host capable of transferring 
suicide plasmids requiring the Pir 
protein via conjugation 
(107) 
S17-1 λ–pir pDM4.2 S17-1 λ–pir containing the suicide 
vector pDM4.2 (GmR) 
(107) 




YpIII Parent pYV+ Y. pseudotuberculosis parent 
strain possessing the virulence 
plasmid pYV, Serotype O:3 (NalR) 
(109) 
YpIII Parent pYV- Parent Y. pseudotuberculosis 
strain cured of the virulence 
plasmid Serotype O:3 (NalR) 
(110) 
YpIII ΔII Y. pseudotuberculosis strain 
lacking the QS synthases ypsI and 
ytbI (CmR, KmR) 
(97) 
YpIII ΔRR Y. pseudotuberculosis strain 
lacking the QS transcriptional 





























S17-1 λ–pir containing the 
plasmid pJd2::copB::luxCDABE 
This Study 
YPIII Parent pYV+ 
pJd2:copA::luxCDABE 
YPIII Parent pYV+ with integrated 
pJd2:copA::luxCDABE plasmid 
This Study 
YPIII Parent pYV+ 
pJd2:copB::luxCDABE 





Y. pseudotuberculosis strain 
lacking the QS synthases ypsI and 





Y. pseudotuberculosis strain 
lacking the QS synthases ypsI and 





Y. pseudotuberculosis strain 
lacking the QS synthases ypsR and 





Y. pseudotuberculosis strain 
lacking the QS synthases ypsR and 














2.2.2 Plasmids used 
Every plasmid used in this study is listed in Table 2.2. 
Table 2.2: Plasmids used within the study. 
Plasmid Description Source 
pGEM-T-easy Cloning vector (AmpR) Promega© 
pBluelux pBluescript II KS+ Vector containing the 
luxCDABE operon (AmpR) 
(98) 
pHG327 Low copy number vector (AmpR) (108) 
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pDM4.2 Pir protein reliant suicide vector Joanne Purves 
(Unpublished) 
pJd1::copA Amplified CopA promoter integrated into the 
cloning vector pGEM-T-Easy (AmpR) 
This study 
pJd1::copB Amplified CopB promoter integrated into the 
cloning vector pGEM-T-Easy (AmpR) 
 
pJd1:copA::luxCDABE The cloning vector pGEM-T-Easy housing the 
amplified PcopA and the luxCDABE cassette 
(AmpR) 
This study 
pJd1:copB::luxCDABE The cloning vector pGEM-T-Easy housing the 
amplified PcopB and the luxCDABE cassette 
(AmpR) 
This Study 
pJd2:copA::luxCDABE The Pir protein dependent suicide plasmid 
pDM4.2 harbouring the amplified PcopA and 
the luxCDABE cassette (GmR) 
This study 
pJd2:copB::luxCDABE The Pir protein dependent suicide plasmid 
pDM4.2 harbouring the amplified PcopB and 
the luxCDABE cassette (GmR) 
This Study 
pJd3:copA::luxCDABE* The vector pHG327 containing both amplified 
PcopA and the luxCDABE cassette (AmpR) 
This study 
pJd3:copB::luxCDABE* The vector pHG327 containing both amplified 
PcopB and the luxCDABE cassette (AmpR) 
This Study 
*Designed only 
2.3 General Genetic Modification 
2.3.1 Molecular Cloning 
2.3.1.1 Plasmid Handling 
The Sigma GenEluteTM Plasmid Miniprep Kit was used for the extraction of plasmids 
throughout. Extracted plasmids were eluted in H2O and stored at -20oC, unless stated 
otherwise. The manufacturer’s instructions were followed throughout. 
2.3.1.2 Restriction Digests 
Restriction enzymes (Promega) were used in accordance to the supplier’s instructions for 
the digestion of plasmids as described by Schagat et al. (111). 
2.3.1.3 Gel Electrophoresis and DNA Extraction 
When performing gel electrophoresis, agarose gels (1.2% (w/v) agarose, 1 x TAE buffer [50 x 
stock solution: 2.0 M Tris-acetate pH 8, 0.05 M ethylene-diamine-tetraacetic acid – EDTA]) 
were used. Each gel contained 0.1 µl/ml SYBRTM Safe gel stain. Wells were loaded with 6 µl – 
25 µl DNA in 6x Promega loading dye and were run alongside DNA ladder (100 bp ladder or 1 
kb ladder – Promega). Gels were run in 1 x TAE buffer at 100 V for 40 minutes. 
When excising DNA, it is necessary to place the agarose gel under a UV light and behind a 
UV shield; this highlights the bands, allowing the bands to be cut out. Using a scalpel to cut 
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out the bands minimises the amount of gel taken that does not contain DNA. Tubes were 
weighed before, and then after the excised gel was added to find the weight of the samples. 
This was used to calculate the volume of gel dissolving buffer that was needed. 
Open vectors, PCR products or DNA excised from agarose were purified using a Monarch® 
DNA Gel Extraction Kit following the supplier’s instructions. 
2.3.1.4 Ligation of Vector and Fragment 
Typically, a 3:1 ratio (varied on occasion) was used along with T4 DNA ligase (Promega) when 
carrying out the ligation of vector, digested DNA fragments or PCR products. Ligations were 
usually incubated overnight alternating between 30oC and 10oC (112). 
2.3.1.5 Transformation of DNA into Competent Cells 
Chemically competent cells were prepared as described by Chang et al. (113) with the 
following modifications: The overnight culture was grown in 5 ml SOB and the dilution was 
also carried out using SOB rather than LB. The concentration of this dilution was also 1:5 to 
begin the next stage at an OD600 of 0.1. Following the subculturing and a 10-minute period of 
incubation in ice, the cells were centrifuged at 2500 x g at 4oC for 20 minutes. The pelleted 
cells were resuspended in 10 ml TB solution, before a further 10-minute incubation period in 
ice. Again, the cells were centrifuged at 2500 x g at 4oC for 10 minutes. The new pellets were 
then resuspended again in 1.86 ml TB solution and 140 µl DMSO 100%. There was a further 
10 minute incubation period in ice before aliquoting 50 µl of cells into tubes to store rather 
than 5 ml as described (113). 
2.3.1.6 Heat-Shock Transformation 
Aliquots containing the appropriate competent cells (E. coli DH5α or E. coli S17-1 λ-pir) were 
thawed on ice before the ligation products were added at a ratio of 1:5. The mixture was then 
incubated on ice for 10 minutes before being placed in a heat block at 40-42oC for 1 minute, 
returned to ice for a further 10 minutes and then LB broth 950 µl was added to the cells. The 
new mixture was incubated at 37oC for 1-2 hours in a shaking incubator. 
After incubation, the cells were added to a 1.5 ml tube before centrifugation at 12,000 x g for 
1 minute. The supernatant was discarded, and 200 μl LB broth was used to resuspend the 
pelleted cells. The cells were then plated onto LB plates with appropriate antibiotics (plus x-
gal where blue/white screening (114) is necessary). The plates were incubated at 37oC 
overnight. 
2.3.2 Polymerase Chain Reaction 
Polymerase chain reactions (PCR) were carried out using non-proofreading Go Taq® DNA 
polymerase (Promega). A standard 25 µl reaction consisted of 1 µl sample (boiled colony, 
gDNA etc.), 13.5 µl H2O, 5 µl reaction buffer (Promega), 1 µl of each forward and reverse 
primers – 10 mM, 3 µl Mg2+ 25 mM, 0.4 µl dNTP’s 10 mM and 0.1 µl Taq® polymerase (115). 
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PCR standard conditions were dependent on the size of the final product and the appropriate 
temperature for the primers used. The polymerase supplier’s (Promega) instructions were 
followed when setting up the reactions. The primers used throughout the study are listed in 
Table 2.3. 
 









RepA2-F GTACTCGAGCTGTTGCTCTATACAGG XhoI This Study 
RepA2-R CCACTAGTTAACCCGGGGTGAACAGGGCCTGGTG SmaI / SpeI This Study 
CopB-F CCACTCGAGCGTACAGTCCAACTCGG XhoI This Study 
CopB-R GGACTAGTCTTCCCGGGGGCACGTTTCGATGAGG SmaI / SpeI This Study 
M13-R TGTAAAACGACGGCCAGT - Promega© 
luxC-R CTACAACATCATAAAGGCC - Marco Grasso 
pDM4-F TAGCGGAGTGTATATCAAGC - Joanne Purves 
(Unpublished) 
 
2.4 Detection of Luminescent colonies 
A dark box was used to detect any light produced by the colonies on the antibiotic plates. 
Wasabi software was used in order to visualise the colonies. This was carried out to confirm 
the plasmid (containing lux) had been successfully inserted into the organism. 
 
2.5 Conjugation 
Cells were mated via conjugation as described by (116). Overnight cultures of the donor E. 
coli S17-1 λ–pir with the suicide plasmid were mixed in the ratios 1:1, 3:1, 5:1 and 9:1 with 
the recipient Y. pseudotuberculosis YpIII (Parent pYV+, ΔII or ΔRR) in 1.5 ml tubes. The cells 
were pelleted at 12,000 x g  for 1 minute and were resuspended in 1 ml YLB broth. The last 
step was repeated but with a resuspension in 30 µl YLB broth. These were spotted onto non-
selective YLB plates. These were incubated for 24 hours at 37oC before the cells were removed 
and resuspended in 0.2 ml YLB broth. This was then split into two and plated on YLB agar 
plates with appropriate antibiotics. These were incubated at 30oC for several days or until 
single colonies were visible. Single colonies (particularly those producing light) were patched 
onto YLB agar plates with the appropriate antibiotics. The patch plates were also incubated 





2.6 Growth Curve 
Any overnight cultures are measured in a spectrophotometer in order to calculate the volume 
needing to be added to the media to begin the curve at an OD of 0.1 (Using C1V1=C2V2). A ratio 
of 1:5 (Media: Container volume) was consistently used. Unless otherwise stated the media 
is YLB broth + the appropriate antibiotic. 
A spectrophotometer is used every 30 minutes for between 6-10 hours to measure the OD600 




















The aim was to identify whether QS plays a role in copA/copB expression, and therefore pYV 
plasmid maintenance. Lux-based reporter fusions were constructed in order to measure the 
level of expression of the copA and copB promoters both in the Y. pseudotuberculosis YPIII 
parent pYV+ strain, and mutants that have altered QS systems, either without the ypsI/ytbI 
ortholog or without the ypsR/ytbR ortholog. 
During the construction of these fusions it was necessary to use pDM4.2, a suicide vector. 
This suicide vector forces the plasmid to integrate in the chromosome/plasmid in the 
desired organism via homologous recombination.  E. coli S17-1 possesses λ-pir which codes 
for the π protein, which is required to activate the origin of replication of pDM4.2 (116). 
When undergoing conjugation, the plasmid is left without the π protein required to undergo 
replication. This selective pressure forces the plasmid to either integrate into the λ-pir 
negative organism’s pYV plasmid between the copA and copB promotors, or no replication 
can occur. Whereas E. coli DH5α (which had been transformed into for each other stage of 
the fusion construction) does not possess the λ-pir gene (and therefore cannot produce the 
π protein) and therefore pDM4.2 would never replicate within the organism (117). As a 
result, E. coli DH5α was used for the other plasmids but not the pDM4.2 derived ones. 
 
3.1 Amplification of CopA/CopB 
The first stage of this process involved extracting gDNA. The plasmid was extracted with the 
gDNA as the chromosome is large in size, causing them to precipitate with the plasmid still 
intact – this allowed the use of pYV as the template for the constructs. The promoter regions 
of copA/copB could then be amplified from the plasmid. gDNA extraction was carried out from 
an overnight Y. pseudotuberculosis YPIII Parent pYV+ culture grown at 30oC. Agarose gel 
electrophoresis was performed to confirm the extracted material was of the quality required 
for use in future cloning steps. Agarose gel electrophoresis revealed that both gDNA samples 
were larger than the ladder as expected, proving chromosomal DNA was present. The first 
sample appears more refined due to a lower quantity of DNA thus less tangling of the 
fragments occurred and the second sample potentially being a larger quantity of DNA (Figure 
3.1a). The concentration of the DNA was also determined using a nanodrop 
spectrophotometer and revealed that sample 1 and 2 contained 43 and 125 ng/µl 
respectively. PCR was then carried out, specifically on the pYV Plasmid Rep Operon, outlined 
in figure 3.2. Using the gDNA (and therefore pYV) as a template, PCR was performed to 
amplify the promoter regions of copA (primers RepA2-F and RepA2-R) and copB (copB-F and 
copB-R) (figure 3.2), and once complete the purified PCR products were analysed using 
agarose gel electrophoresis. Figure 3.1b reveals that the PCR worked as expected for copA 
and copB and amplified fragments of 149 bp (lanes 7-9) and 330 bp (lanes 2-4) respectively. 
Both 100 bp ladders (wells 6 and 11) did not separate as hoped for. However, this was not an 
issue as the 1 kb ladder worked as hoped. The appropriate bands (figure 3.1b - lanes 2-4, 8 
and 9) were extracted from the gel, cleaned and re-analysed using agarose gel 
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electrophoresis, revealing that the extraction was successful and the fragments of 149 bp 







Figure 3.2: The pYV Rep Operon from Y. pseudotuberculosis, of which the copA and copB 
promoter regions were amplified. The purple labels indicate the locations of the primers (copB-
F, copB-R, repA2-F, and repA2-R) used to amplify the regions.  
Figure 3.1: The prepared gDNA of Y. pseudotuberculosis YPIII PYV+ reveals the eligibility of the 
gDNA for use in the cloning process (A). In gel A: 1 kb ladder (1), and gDNA samples (2 & 3). The 
PCR products of the copA and copB promoter regions when using RepA2-F & RepA2-R primers 
for copA, and copB-F & copB-R for copB (B). This shows that the PCR worked correctly, with the 
correct fragments being formed. In gel B: 1 kb ladder (1), copB (2-4), copA (7-9), negative controls 





3.2 Cloning of copA/copB into pGEM-T Easy 
The next phase of the fusions involved cloning the amplified copA and copB fragments into 
the cloning vector pGEM-T Easy. A gel was run before carrying out a ligation to check both 
inserts, copA and copB (figure 3.3a). The expected size of the bands were 149 bp for copA and 
330 bp for copB. The band at lane 2 is in between the 100 bp and 200 bp markers, suggesting 
that the copA fragment was as expected. Lane 3 can be seen between the 300 bp and 400 bp 
markers, also suggesting that the copB fragment was as expected. Both ladders (lanes 1 and 
4) separated as hoped, though the 1 kb ladder was slightly distorted due to piercing of the 
well when adding the ladder. A ligation could then be carried out using the copA/copB 
fragments as inserts and pGEM-T Easy as a vector. The ligated products were then 
transformed into E. coli DH5α via heat-shock transformation. This strain allowed the use of 
blue-white screening – a mechanism that is based around β-galactosidase (a protein encoded 
by the lacZ gene) detection. X-gal allows for the detection of β-galactosidase activity, as the 
enzyme cleaves X-gal to form 5-bromo-4-chloro-indoxyl, which forms a blue insoluble 
pigment. When the lacZα gene is interrupted, for example via an insertion, its production of 
α-peptides is disrupted, preventing the formation of functional β-galactosidase. As a result, 
when X-gal is added, no cleaving takes place and therefore no colour change occurs (118). 
Blue-white screening was used to identify colonies containing pJd1::copA/pJd1::copB. PCR 
was carried out on these positive colonies to amplify the copA (using the primers repA2-F and 
M13-R) or copB (using the primers copB-F and M13-R) regions within the plasmid, and a gel 
was run to confirm the presence of the insertion. This gel (figure 3.3b) revealed copA and 
copB were present in the positive colonies that were tested – with the expected size of copA 
being 281 bp and the expected size of copB being 462 bp. Both sets of bands (5-7 and 10-14) 
were in the region of these anticipated sizes. The gel confirmed that copA and copB were 
successfully inserted in to pGEM to give pJd1::copA and pJd1::copB (figure 3.4). 
Figure 3.3: The gel before ligation reveals that the extracted material from previously is usable, 
and that the fragments have not been damaged or diluted in the process of extraction (A). In gel 
A: 100 bp ladder (1), copA (2), copB (3), and a 1 kb ladder (4). To confirm the creation of pJd1, 
PCR had to be carried out on seemingly positive colonies and the bands visualised to ensure the 
correct new fragment sizes are present (B). In gel B: 100 kb ladder (1), 100 bp ladders (2 & 9), 





3.3 Subcloning of the luxCDABE cassette 
Step 3 in the fusion production was to combine both pJd1::copA and pJd1::copB with the lux 
cassette from pBlue-lux to produce the new plasmids pJd1:copA::luxCDABE and 
pJd1:copB::luxCDABE. The lux cassette component is the means of measuring expression in 
the final fusions, along with providing an easier screening method of using light. This works 
through the promoter (either from copA or copB) being activated, which switches leads to the 
expression of both QS components luxI and luxR, and also luxCDABE. This expression leads to 
bioluminescence of the cells. The greater the activity of the promoter, the greater the 
production of light. Minipreps were performed to isolate pJd1::copA, pJd1::copB, and pBlue-
lux (a plasmid containing the luxCDABE cassette); following restriction of the newly isolated 
plasmids using the enzymes SmaI and SpeI, the resulting products were analysed on an 
agarose gel, before being extracted and cleaned. Once clean, the samples were again 
analysed on an agarose gel (figure 3.5a) which revealed that both vectors (pJd1::copA and 
pJd1::copB) ran at approximately 3 kb and matched to their expected sizes of 3,146 bp and 
3,327 bp respectively. Similarly, the insert (luxCDABE cassette), digested from pBlue-lux, ran 
at approximately 6 kb, with the expected size being 5,864 bp. Following this check, ligations 
of both vectors and insert were carried out, leading to transformation into E. coli DH5α. 
Positive colonies were screened for light which was indicative of the successful insertion of 
luxCDABE into pJd1::copA and pJd1::copB, with the positive colonies being tested by 
performing PCR using repA2-F and luxC-R primers for copA, and copB-F and luxC-R for copB. 
The PCR products were then visualised on a gel (figure 3.5b). Figure 3.5b reveals the PCR 
worked as expected for both copA and copB, where the amplified fragments of 524 bp (lanes 
3 & 4) and 705 bp (lanes 6 & 7), appear to be in the correct regions when compared to the 
ladders.  As a result it was confirmed that luxCDABE had been successfully inserted into both 
Figure 3.4: The plasmid maps of both pJd1::copA (A) and pJd1::copB (B). The purple labels 
indicate the sites of primers (repA2-F, copB-F, and M13 Fwd/M13 rev). The plasmids contain a 









Figure 3.6: The plasmid maps of pJd1:copA::luxCDABE (A) and pJd1:copB::luxCDABE (B). The 
purple labels indicate the use of primers in these locations. Among these are the M13 primers, 
that are instead indicated with labels inside the plasmid maps. The plasmids consist of pGEM-T 
Easy, the amplified promoter regions of copA and copB, and a lux cassette from pBluelux. 
A B 
Figure 3.5: Samples of the extracted/cleaned vectors and insert were visualised to ensure the 
newly digested fragments were still of a good quality, and that the clean-up of the vectors had 
been a success before using them in the next stage of the cloning process (A). In gel A: 1 kb ladder 
(1), lux (2), pJd1::copA (3), and pJd1::copB (4). PCR was carried out on seemingly positive 
colonies, with the results being visualised to reveal whether the fragment sizes are as 
anticipated, confirming the creation of the new plasmids (B). In gel B: 1 kb ladder (1), 100 bp 





3.4 Subcloning of copA::luxCDABE/copB::luxCDABE into pDM4.2 
It was then necessary to use pDM4.2 as a new vector, with the copA/copB and luxCDABE 
portions of pJd1:copA::luxCDABE and pJd1:copB::luxCDABE being inserted. pDM4.2 was 
chosen for its properties as a suicide vector. Restriction digests were performed on pDM4.2, 
pJd1:copA::luxCDABE, and pJd1:copB::luxCDABE using SpeI and XhoI sites, and agarose gel 
electrophoresis was carried out on the digested products. Gel extraction and ligation were 
then performed using pDM4.2 as a vector and the digest products copA::luxCDABE and 
copB::luxCDABE as the inserts. The ligations were heat-shock transformed, into E. coli S17-1 
λ-pir as it encodes the π protein required for the replication of pDM4.2. Once the 
transformants grew, they were screened using a dark box to identify bioluminescent colonies, 
and PCR. Figure 3.7a reveals following PCR screening (using the primers luxC-R and pDM4-F) 
colonies contain pJd2:copA::luxCDABE with the expected band size being 559 bp (lanes 2-5). 
Each of the bands were in the region of this anticipated size. Similarly, figure 3.7b reveals 
following screening via PCR (using the primers luxC-R and pDM4-F) the other screened 
colonies contain pJd2:copB::luxCDABE with the expected size of these bands being 740 bp 
(lanes 2-5). This confirmed that pJd1:copA::luxCDABE and pJd1:copB::luxCDABE had both 
been successfully ligated into pDM4.2 to produce pJd2:copA::luxCDABE and 
pJd2:copB::luxCDABE. 
Conjugations were carried out using pJd2:copA::luxCDABE and pJd2:copB::luxCDABE with Y. 
pseudotuberculosis YPIII Parent pYV+, Y. pseudotuberculosis YPIII ΔRR, and Y. 
pseudotuberculosis YPIII ΔII (the genetic backgrounds of these strains can be found in table 
2.1). The conjugations were screened using both light detection and PCR to confirm the 
presence of the fusions. 
 
Figure 3.7: PCR was carried out on light positive colonies containing pJd2:copA::luxCDABE to 
ensure the fusion was correctly created (A). In gel A: 1 kb ladder (1), copA (2-5), and a negative 
control (6). Similarly, PCR was carried out on the pJd2:copB::luxCDABE based fusion to ensure it 





3.5 Subcloning of copA::luxCDABE/copB::luxCDABE into pHG327 
pHG327 (figure 3.10) was used as a vector, to be able to compare the integration method 
involving the suicide plasmid pDM4.2 and another set of fusions that are instead transformed 
into the cells. For transformation, we sought a vector that had a low copy number, to reflect 
natural expression. Each additional copy of the fusions would lead to greater light production, 
which could cause inaccuracies. As such, pHG327 was selected for its exceptionally low copy 
number (which at times is just 3-5). While not perfect, it is an alternative in case the 
integration method does not work as hoped for, which can at times occur when integrating 
via a suicide plasmid.  
The pJd2:copA::luxCDABE and pJd2:copB::luxCDABE plasmids were taken from E. coli S17-1 λ-
pir rather than using those that are integrated into the Yersinia strains. This was because the 
restriction sites were easier to work with at this stage in the fusions. pHG327 was prepared 
and digested alongside pJd2:copA::luxCDABE and pJd2:copB::luxCDABE using the restriction 
site SalI (figure 3.8), which is also a single site in the pHG327 MCS (figure 3.10). There are risks 
associated with using a single restriction site, the first being self-ligation of the insert/vector. 
Another risk is orientation – if the insert and vector are ligated successfully, there is a risk that 
the insert may be in the incorrect orientation and thus not function correctly. A way to 
prevent this was to dephosphorylate the vector before carrying out the ligation, this prevents 
self-ligation occurring. The digested products were visualised on a gel. This process had to be 
repeated several times, with a few variations in how pHG327 was handled. The growth media 
was changed to Brain Heart Infusion (BHI) agar, which is richer in nutrients, to encourage 
greater cell growth following a lack of visual bands when carrying out gels. Once successful, a 
ligation was carried out with an altered ratio of 5:1 with pJd2:copA::luxCDABE and 
pJd2:copB::luxCDABE as the inserts and pHG327 as the vector. Previous ligations had been 
carried out using high copy number plasmids, as such the ratio was increased to improve the 
chances of a successful ligation when using a low copy number plasmid. A transformation was 
then undertaken using E. coli S17-1 λ–pir and the plates were screened for potential positive 
colonies using a combination of light detection and PCR. Figure 3.9 reveals the process was 
unsuccessful, with the expected band sizes being approximately 6 kb and 3.4 kb (wells 1-4). 
Both bands were above the expected sizes, along with the presence of an unexpected third 
band, which may be the result of a partial digest. As a result the construction of 
pJd3:copA::luxCDABE and pJd3:copB::luxCDABE could not be confirmed and will need 
repeating when possible to do so. 
Figure 3.8: The plasmid maps of pJd2:copA::luxCDABE (A) and pJd2:copB::luxCDABE (B). Primer 
locations are highlighted in purple text. These plasmids consist mostly of pDM4.2, along with 
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PCR Screening of pJd3 constructs 
Figure 3.9: PCR was carried out on light colonies, and in the case of copA, colonies that 
sufficiently grew, following a lack of light consistently in these constructs. In this gel: 
pJd3:copB::luxCDABE  (1 & 2), pJd3:copA::luxCDABE (3 & 4), and a 1 kb ladder (5). It was hoped 
that this gel would confirm the construction of both plasmids. 
Figure 3.10: A map of the cloning vector pHG327, including each restriction site it possesses. 
The group of these sites is located on the Multi-cloning site (MCS), to ease the digestion process 




The study aimed to learn whether QS plays a role in copA/copB and therefore pYV plasmid 
maintenance. This was attempted through the construction of lux-based reporter fusions, in 
order to measure the level of expression of copA and copB promoters when the QS synthases, 
ypsI/ytbI or ypsR/ytbR, are removed from the quorum sensing system within Y. 
pseudotuberculosis. These were previously removed through deletions as described by 
Atkinson et al. (97). 
 
Amplification of copA/copB promoters 
The processes involved in extracting gDNA from the parent culture of Y. pseudotuberculosis 
YPIII PYV+ went smoothly, as did the amplification of both promoter regions of copA and copB. 
The only mishap was a lack of separation in the 100 bp ladders, which did not impact on this 
stage due to a 1 kb ladder also being used. 
 
Cloning of copA/copB promoters into pGEM-T Easy 
At the second stage of the fusion production, the amplified regions of copA/copB were 
inserted into the vector pGEM-T Easy. Most of the process was straight forward with no 
errors. However, there was one minor issue when it came to the gel, whereby the gel was 
pierced by the pipette tip when adding the 1 kb ladder (figure 3.3a) which created a slightly 
deformed ladder, though this did not impact on the ability to read the gel. The only other 
issue with this stage of the fusion construction was the blue-white screening. The screening 
worked effectively with copB as the larger insertion disrupted the lacZ to a larger extent, 
preventing the production of effective α-peptides, in order to produce β-galactosidase. 
However, the copA insert is smaller in size and as a result the disruption to the lacZ gene 
sequence is minimal. This led to some colouration in the colonies regardless of whether the 
insert was present or not. The problem was solved by continuing to target the white or the 
palest blue colonies formed, suggesting there is only a limited production/inactivation of β-
galactosidase, as a result of abnormal or very few α-peptides being produced (118). 
 
Subcloning of luxCDABE to create the reporter fusions 
The next step involved the insertion of the pBluelux luxCDABE cassette into pJd1::copA and 
pJd1::copB. This was necessary to measure the levels of expression within the fusions, along 
with the use of light as a method of screening for positive colonies. There were no issues 





Subcloning of copA::luxCDABE/copB::luxCDABE into pDM4.2 
At this stage, the aim was to produce pJd2:copA::luxCDABE and pJd2:copB::luxCDABE, which 
possess the qualities of a suicide plasmid due to the involvement of pDM4.2. These plasmids 
were then integrated into Y. pseudotuberculosis YPIII Parent pYV+, and the mutants Y. 
pseudotuberculosis YPIII ΔRR, and Y. pseudotuberculosis YPIII ΔII. Several issues arose 
throughout this step, all of which were during the process of conjugation and not the creation 
of the fusions themselves. Several repeats were necessary for most of the constructs. The first 
of these reasons was a lawn of bacterial growth over the conjugation plates, rather than the 
desired individual colonies. The likely cause of this is too large a quantity of viable cells, 
causing exponential growth of cells, leading to the lawn of bacteria. As a result, the ratio of 
9:1 (the largest ratio that had been already carried out previously in the study) was focussed 
on for these constructs to reduce the number of viable cells and as a result dilute the contents 
of the plates – this was successful after a few attempts. The next issue was a lack of light being 
picked up for the copA-based constructs. After attempting to alter the method in a variety of 
ways including change in ratio, volume etc. it was realised that the copA-based fusions are 
likely to have produced light very early in their growth and as a result this light production 
was usually missed. It is likely that the early light production is down to rate of growth of the 
organism. Light production occurs during the exponential growth phase of the bacteria’s 
typical growth curve (119; 120). This difference in growth rate could be attributed to the 
difference in metabolic load between the two different fusions. As the copB fusion is larger in 
size, the bacterium carries a slightly higher metabolic load, whereas the copA fusion is smaller, 
slightly reducing the metabolic load. It has been suggested that a higher metabolic load/larger 
plasmid leads to a slower growth rate in otherwise identical bacteria (67). To counter this, 
patch plates were created so that PCR could be used on several different colonies rather than 
relying on light. Screening via PCR is advantageous because it reveals whether the colonies 
contain specific components of the fusions, rather than relying on just a functioning lux 
cassette. The introduction of the patch plates allowed for repeats of PCR if necessary, along 
with increasing light visibility due to the higher quantity of bacteria. 
 
Subcloning of the reporter fusions into pHG327 
To create the alternative fusions, the reporter regions (lux and copA/B) of 
pJd2:copA::luxCDABE and pJd2:copB::luxCDABE were inserted into pHG327. The intention of 
this alternative set of fusions is to transform the plasmid directly into Y. pseudotuberculosis 
cells, compared to forcing integration via a suicide plasmid. pHG327 was the chosen vector, 
as it possesses an extremely low plasmid copy number. Each additional copy leads to a greater 
production of light, therefore decreasing the accuracy when measuring expression using 
luxCDABE as a marker. Although not perfect, the low copy number should more accurately 
reflect the expression from the native promoters, which may not be possible with the other 
fusions. There may be issues with the pDM4.2 fusions as this method does not always lead to 
successful integration via homologous recombination due to this needing to occur between 
the copA and copB promoters, with only a single copy of the plasmid. The pHG327 method 
removes the struggle of integrating the reporters via homologous recombination.  
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There were consistent issues with this process, starting with the struggle to visualise a band 
of pHG327 on a gel following a digestion. This issue is common with low copy number 
plasmids due to a limited quantity of DNA to work with. To try to fix this problem, the growth 
media for E. coli pHG327 was changed from LB agar to BHI agar to increase the nutrients 
available, therefore encouraging greater growth and as a result gain more genetic material to 
work with. Other methods of increasing the plasmid yield could have included increasing the 
volume of the starting culture, subculturing from a single colony, or attempting a variety of 
different growth conditions such as length of time. The chosen method seemed to work and 
resulted in the production of bands on a gel. A ligation and transformation were carried out, 
with the resulting colonies being screened via PCR. Despite the change in media, the 
subcloning process failed. Bands were visualised as hoped for, but the sizes of these bands 
were not what was expected (figure 3.9). At this point, the project had to pause, preventing 
a repeat of this process. 
 
Research plans for further work 
The plan was to carry out Bioluminescence assays using a Tecan Spark® microplate reader 
with SparkControl software on the fusions to find any differences in level of expression of 
copA/copB, in order to gain an understanding of the role of QS in plasmid maintenance. The 
assays would consist of each fusion in the parent and QS mutants and would allow for 
comparison to identify what components of the QS system are important in plasmid 
maintenance. It would highlight whether there is a difference in copA and copB expression, 
along with identifying if the I or R orthologs play a significant role in the process. If 
downregulation occurs in the mutants compared to the parent strain, it could be suggested 
that QS has a positive regulatory role in the copA and/or copB promoters (110). It has 
previously been found that when not bound to autoinducers (AI), LuxR proteins are rapidly 
degraded, presumably to prevent bacteria from short-circuiting their QS systems (94). 
However, if upregulation of expression occurs, it may be that the QS system still has an 
important role in plasmid maintenance, but a repressive role. The assays ultimately would 
identify or further prove the relationship between each component of the pYV plasmid 
maintenance system. It was also intended to produce a set of pHG327 based fusions. These 
would also have been tested with Tecan assays to act as a comparison to the suicide plasmid-
based fusions. While the light output/levels of expression may differ between the two sets of 
fusions, if the trend in data is identical it would suggest the results are accurate, without the 
possibility of inaccuracy when two different approaches reach the same conclusion. 
If there was a mutant that stood out in terms of results, then this information could be taken 
further into producing single Y. pseudotuberculosis ΔI or ΔR to identify which individual 
component of each pairing (for example yspI vs ytbI, or yspR vs ytbR) has the greater impact 
on QS, or if there even is a difference within the pairs. 
To also further test the theory that QS plays a role in Yersinia plasmid maintenance, it would 
be interesting to follow up the Tecan assays with using a variety of QS inhibiting compounds 
to see if this influences the expression of copA and copB. An example of this could be 
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flavanones, such as naringin, neohesperidin, and hesperidin, all of which have been seen to 
possess anti-QS characteristics. The study by Truchado et al. (121) on these compounds 
revealed orange extract’s main flavanone components exert a QS inhibitory effect on Y. 
enterocolitica. It was proven that the AHL level was reduced dramatically when introducing 
these flavanones. The impacts also continued in biofilm formation and motility, both of which 
were reduced significantly. This is supported by another previous study based on 
Pseudomonas aeruginosa where similar effects were observed on the organism’s QS 
mechanisms (122). If the levels of expression changed as a result of these compounds, it 
would suggest that either copA, copB, or both, are influenced by QS. 
This work could be followed up by using the aiiA gene, which encodes for an autoinducer 
inactivating enzyme (123). This gene could be inserted into the existing fusions to degrade 
AHLs produced by the QS system. The new fusions could be used in the same way that both 
ΔII and ΔRR Y. pseudotuberculosis mutants were, preventing the QS system working as it 
normally would and discovering whether the expression of copA and copB is affected. 
However, this method may be better as it does not require the removal of either I/R ortholog. 
There is potential risk that any component in these orthologs may have an additional role that 
we are unaware of. With the aiiA gene approach, this risk factor is removed. 
Another potential direction could be to use the aiiA gene in the fusions, but measure plasmid 
loss rather than expression of copA/copB. Plasmid loss could be assessed using the luxCDABE 
cassette as a marker of plasmid presence, meaning those colonies without light have lost the 
plasmid. While the data in this case would be related to plasmid loss, the results would have 
implications on plasmid maintenance if there was a difference between the fusions containing 
the aiiA gene and those such as pJd2:copA::luxCDABE and pJd2:copB::luxCDABE, within the 
parent strain of Y. pseudotuberculosis. 
A possible target to look into for the future could be the ParDE Toxin-Antitoxin system. Whilst 
not extensively characterised in Yersinia, it was discovered that there are ParDE homologues 
on pCD1 in Yersinia pestis along with a presence on the chromosome of Y. enterocolitica (124). 
The system is known to contribute to stable maintenance of the RK2 plasmid within 
Escherichia coli and several related bacteria (125; 126), along with promoting biofilm 
formation (126). This information leads me to believe the system is worth further 
investigation within Yersinia. Biofilm formation has close links to QS, and as ParDE has links 
to both biofilm formation and plasmid maintenance within E. coli (which has several similar 
characteristics to Yersinia) QS and this system may overlap. However, ParDE and its functions 
within Yersinia are unknown and as such the system would need characterisation before 
moving on to investigate possible ties between the TA system, QS and plasmid maintenance. 
 
Conclusion 
In conclusion, whilst the data for the constructs could not be gathered at this point, strides in 
the right direction were made. The first set of fusions were successfully created, allowing 
them to be used to collect data when it is possible. pJd3:copA::luxCDABE and 
pJd3:copB::luxCDABE were not finished and as a result will need to be created upon 
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continuation of the project. It will be at this point, when both sets of fusions can be compared 
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